DrugPatentWatch Database Preview
Investigational Drug Information for Motesanib
Email this page to a colleague
What is the drug development status for Motesanib?
Motesanib is an investigational drug.
There have been 13 clinical trials for Motesanib.
The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2012.
The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Breast Neoplasms. The leading clinical trial sponsors are Amgen, National Cancer Institute (NCI), and Takeda.
There are six hundred and twenty-one US patents protecting this investigational drug and six international patents.
Summary for Motesanib
| US Patents | 621 |
| International Patents | 6,839 |
| US Patent Applications | 2,058 |
| WIPO Patent Applications | 1,346 |
| Japanese Patent Applications | 709 |
| Clinical Trial Progress | Phase 2 (2012-07-01) |
| Vendors | 73 |
Recent Clinical Trials for Motesanib
| Title | Sponsor | Phase |
|---|---|---|
| Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer | Amgen | Phase 1/Phase 2 |
| Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer | Susan G. Komen Breast Cancer Foundation | Phase 1/Phase 2 |
| Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer | Sidney Kimmel Cancer Center at Thomas Jefferson University | Phase 1/Phase 2 |
Clinical Trial Summary for Motesanib
Top disease conditions for Motesanib
Top clinical trial sponsors for Motesanib
US Patents for Motesanib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Motesanib | ⤷ Sign up for a Free Trial | Pyrrolidinone derivatives as MetAP-2 inhibitors | Merck Patent GmbH (Darmstadt, DE) | ⤷ Sign up for a Free Trial |
| Motesanib | ⤷ Sign up for a Free Trial | Combined application of isothiocyanate compound and anti-cancer medicine | JC (Wuxi) Company, Inc. (Wuxi, Jiangsu, CN) | ⤷ Sign up for a Free Trial |
| Motesanib | ⤷ Sign up for a Free Trial | Compositions and methods for the treatment of intraocular neovascularization and/or leakage | Retinal Therapies, LLC (Coronado, CA) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Motesanib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Motesanib | Argentina | AR101414 | 2034-08-04 | ⤷ Sign up for a Free Trial |
| Motesanib | Australia | AU2015299431 | 2034-08-04 | ⤷ Sign up for a Free Trial |
| Motesanib | Brazil | BR112017000730 | 2034-08-04 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
